OPRX (OptimizeRx) Payments of Debt: $-34.60 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPRX OptimizeRx Corp OPRX
56 GF Score
Price $8.04
GF Value $11.31
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is OptimizeRx Payments of Debt?

OptimizeRx OPRX +2.68% 56 Payments of Debt is $-34.60 Mil as of Jun. 2026. GuruFocus rates OPRX with a GF Score™ of 56/100 and a GF Value™ of $11.31 (Modestly Undervalued). The stock has 3 warning signs investors should review.

OptimizeRx's Payments of Debt for the three months ended in Jun. 2026 was $-28.91 Mil.

OptimizeRx's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was $-34.60 Mil.

OptimizeRx Payments of Debt Related Terms

OptimizeRx Payments of Debt Historical Data

* Premium members only.

The historical data trend for OptimizeRx's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptimizeRx Payments of Debt Chart

OptimizeRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1.71 -4.00 -8.00

OptimizeRx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.50 -0.50 -2.50 -2.69 -28.91
OPRX
56GF Score
OptimizeRx Corp OPRX
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OptimizeRx Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-34.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-34.60 Mil mean?
OptimizeRx (OPRX) has a Payments of Debt of $-34.60 Mil as of Jun. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on OptimizeRx and its competitors.
Is OptimizeRx's Payments of Debt too high?
OptimizeRx's current Payments of Debt is $-34.60 Mil. Overall, OptimizeRx has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's Payments of Debt compare to LFMD and HCAT?
OptimizeRx's Payments of Debt of $-34.60 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Healthcare Providers & Services company?
A good Payments of Debt depends on the Healthcare Providers & Services industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on OptimizeRx and its competitors. OptimizeRx's current Payments of Debt is $-34.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.31, compared to a current price of $8.04 — trading 28.9% below its estimated fair value. The current Payments of Debt is $-34.60 Mil. OptimizeRx's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For OptimizeRx (OPRX), the current Payments of Debt is $-34.60 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OptimizeRx (OPRX) Overvalued in 2026?

Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued. The current stock price of $8.04 is trading 28.9% below its estimated GF Value™ of $11.31. GuruFocus considers OptimizeRx to be Modestly Undervalued.

Key valuation signals for OPRX:

  • Payments of Debt: $-34.60 Mil
  • GF Value™: $11.31 vs. price of $8.04 (28.9% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OptimizeRx Business Description

Address 260 Charles Street, Suite 302, Waltham, MA, USA, 02453
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
56GF Score

Get the complete analysis for OPRX

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.04
Price
$11.31
GF Value